Ocean Biomedical, Inc.
NASDAQ:OCEA
0.9774 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.305 | 0.028 | 0.393 | 0 | 1.858 | 3.192 | 3.198 | 3.194 | 2.662 | 2.664 | 25.413 | 0 | 0 |
| General & Administrative Expenses
| 2.35 | 2.652 | 4.83 | 0 | 1.315 | 3.708 | 1.912 | 4.984 | 2.226 | 2.676 | 18.526 | 0.835 | 0.012 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0.055 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.35 | 2.652 | 4.83 | 0.614 | 1.37 | 3.708 | 1.912 | 4.984 | 2.226 | 2.676 | 18.526 | 0.835 | 0.012 |
| Other Expenses
| -0.003 | -0.001 | -12.677 | 0 | 0.001 | -0.699 | 0.001 | 0 | 0.002 | 0 | 0 | 0.049 | 0 |
| Operating Expenses
| 2.655 | 2.68 | 5.223 | 0.614 | 1.37 | 6.9 | 5.11 | 8.178 | 4.888 | 5.34 | 43.939 | 0.884 | 0.012 |
| Operating Income
| -2.655 | -2.68 | -5.223 | -0.614 | -1.37 | -6.9 | -5.11 | -8.178 | -4.888 | -5.34 | -43.939 | -0.884 | -0.012 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -11.432 | -9.68 | -62.178 | 1.024 | 0.352 | -0.433 | -0.265 | 0.002 | 0.002 | -0.001 | 0 | -0.001 | 0 |
| Income Before Tax
| -14.087 | -13.028 | -67.401 | 0.41 | -1.018 | -7.333 | -5.375 | -8.178 | -4.886 | -5.341 | -43.939 | -0.885 | -0.012 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.04 | 0.668 | 60.635 | -0.055 | -0.027 | 0.433 | -0.001 | -0.069 | -0.002 | 0.001 | -0.055 | 0.001 | -0.047 |
| Net Income
| -14.087 | -13.028 | -128.036 | 0.41 | -1.018 | -7.766 | -5.374 | -8.178 | -4.884 | -5.342 | -43.939 | -0.886 | -0.012 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.53 | -0.49 | -5.16 | 0.031 | -0.077 | -0.73 | -0.27 | -3.1 | -0.36 | -0.4 | -1.35 | -0.044 | -0 |
| EPS Diluted
| -0.53 | -0.49 | -5.16 | 0.031 | -0.077 | -0.73 | -0.27 | -3.1 | -0.36 | -0.4 | -1.35 | -0.044 | -0 |
| EBITDA
| -2.655 | -2.681 | -17.9 | -0.614 | -1.37 | -6.901 | -5.109 | -8.178 | -4.888 | -5.34 | -43.939 | -0.884 | -0.012 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |